Skip to main content
Top
Published in: Ophthalmology and Therapy 1/2024

Open Access 15-11-2023 | ORIGINAL RESEARCH

Chronic Central Serous Chorioretinopathy in Elderly Subjects: Structure and Blood Flow Characteristics of Retina and Choroid

Authors: Pei Liu, Haixin Fang, Guangqi An, Bo Jin, Chenyu Lu, Shu Li, Fan Yang, Liping Du, Xuemin Jin

Published in: Ophthalmology and Therapy | Issue 1/2024

Login to get access

Abstract

Introduction

With advancements in imaging technology, researchers have been able to identify more distinctive imaging features of central serous chorioretinopathy (CSC). However, existing research primarily concentrates on young patients aged 50 years and below, leaving a dearth of studies on elderly CSC patients. Previous studies indicate that elderly CSC patients may exhibit unique imaging characteristics and have a clinical prognosis that significantly differs from younger patients. This study aimed to evaluate the characteristics of retina, choroid structure, and blood flow in elderly patients with chronic CSC (cCSC) examined multimode imaging and try to find new pathogenesis information of it.

Methods

Using a cut-off age of 50 years, patients with chronic central serous chorioretinopathy were divided into two groups: older and younger. The control group consisted of 40 healthy individuals, with their right eyes assigned. Various clinical features were recorded, including the incidence of ellipsoid zone rupture (EZ-), fibrin in the subretinal fluid (SRF), pachydrusen, subretinal drusenoid deposits (SDD), pigment epithelial detachment (PED), double-layer sign (DLS), and choroidal lipid globule cavern. Measurements were taken for the thickness of the outer nuclear layer (ONL), the length of the extended outer photoreceptor segment (POS), the height and width of SRF, the vascular density of each layer of the retinal capillary plexus, the central macular thickness (CMT), and the subfoveal choroidal thickness (SFCT).

Results

The proportion of females in the elderly group (43.75%) was significantly higher than that in the youth group (22.41%) (p = 0.034). The degree of hyperopia in the elderly group (1.03 ± 0.73) was higher than that in the youth group (0.26 ± 1.06), with a significant difference in BCVA (p = 0.05). The thickness of SFCT, CMT, ONL in the elderly group, and the length of photoreceptor outer segment in the elderly group were thinner than those in the youth group (p < 0.05). Choroidal capillary perfusion area (CCPA), macular area, and paramacular area were lower in the elderly group than those in the youth group in the full scan range (p < 0.05). The blood flow densities of deep capillary plexus (DCP), intermediate capillary plexus (ICP), and superficial capillary plexus (SCP) in the whole scan range, macular area, and paramacular area were lower in the elderly group than in the youth group, but the differences were not statistically significant.

Conclusions

In conclusion, our data suggest that elderly patients with cCSC may experience different disease outcomes. Elderly cCSC patients exhibit less gender bias, poorer vision, more severe structural damage and ischemia in the choroid and retina, and have a higher risk of developing choroidal neovascularization.
Literature
1.
go back to reference Hu J, Qu J, Piao Z, et al. Optical coherence tomography angiography compared with indocyanine green angiography in central serous chorioretinopathy. Sci Rep-UK. 2019;9(1):6149.CrossRef Hu J, Qu J, Piao Z, et al. Optical coherence tomography angiography compared with indocyanine green angiography in central serous chorioretinopathy. Sci Rep-UK. 2019;9(1):6149.CrossRef
2.
go back to reference Wu M, Fan W, Chen Q, et al. Three-dimensional continuous max flow optimization-based serous retinal detachment segmentation in SD-OCT for central serous chorioretinopathy. Biomed Opt Express. 2017;8(9):4257–74.PubMedPubMedCentralCrossRef Wu M, Fan W, Chen Q, et al. Three-dimensional continuous max flow optimization-based serous retinal detachment segmentation in SD-OCT for central serous chorioretinopathy. Biomed Opt Express. 2017;8(9):4257–74.PubMedPubMedCentralCrossRef
3.
go back to reference Kyo A, Yamamoto M, Hirayama K, et al. Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy. Sci Rep-UK. 2021;11(1):8973.CrossRef Kyo A, Yamamoto M, Hirayama K, et al. Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy. Sci Rep-UK. 2021;11(1):8973.CrossRef
4.
go back to reference Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121(1):26–34.PubMedCrossRef Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121(1):26–34.PubMedCrossRef
5.
go back to reference Podkowinski D, Foessl B, de Sisternes L, et al. Early alterations in retinal microvasculature on swept-source optical coherence tomography angiography in acute central serous chorioretinopathy. Sci Rep-UK. 2021;11(1):3129.CrossRef Podkowinski D, Foessl B, de Sisternes L, et al. Early alterations in retinal microvasculature on swept-source optical coherence tomography angiography in acute central serous chorioretinopathy. Sci Rep-UK. 2021;11(1):3129.CrossRef
6.
go back to reference Kishi S, Matsumoto H, Sonoda S, Hiroe T, Sakamoto T, Akiyama H. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy. PLoS ONE. 2018;13(11): e206646.CrossRef Kishi S, Matsumoto H, Sonoda S, Hiroe T, Sakamoto T, Akiyama H. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy. PLoS ONE. 2018;13(11): e206646.CrossRef
7.
go back to reference Pollithy S, Hoh A, Dobner B, Auffarth GU, Dithmar S. Are there diurnal variations in choroidal thickness? Ophthalmologe. 2015;112(8):665–9.PubMedCrossRef Pollithy S, Hoh A, Dobner B, Auffarth GU, Dithmar S. Are there diurnal variations in choroidal thickness? Ophthalmologe. 2015;112(8):665–9.PubMedCrossRef
8.
go back to reference Hosoda Y, Yoshikawa M, Miyake M, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci USA. 2018;115(24):6261–6.PubMedPubMedCentralCrossRef Hosoda Y, Yoshikawa M, Miyake M, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci USA. 2018;115(24):6261–6.PubMedPubMedCentralCrossRef
9.
go back to reference Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina-J Ret Vit Dis. 2009;29(10):1469–73. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina-J Ret Vit Dis. 2009;29(10):1469–73.
10.
go back to reference Mao J, Lin J, Zhu L, et al. Quantitative assessment of retinal capillary vessel density and foveal avascular zone area in central serous chorioretinopathy using OCTA. Ophthalmologica. 2020;243(5):370–8.PubMedCrossRef Mao J, Lin J, Zhu L, et al. Quantitative assessment of retinal capillary vessel density and foveal avascular zone area in central serous chorioretinopathy using OCTA. Ophthalmologica. 2020;243(5):370–8.PubMedCrossRef
11.
go back to reference Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070–9 (2079-2080).PubMedCrossRef Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070–9 (2079-2080).PubMedCrossRef
12.
go back to reference Komatsu H, Young-Devall J, Peyman GA, Yoneya S. Choriocapillary blood propagation in normal volunteers and in patients with central serous chorioretinopathy. Brit J Ophthalmol. 2010;94(3):289–91.CrossRef Komatsu H, Young-Devall J, Peyman GA, Yoneya S. Choriocapillary blood propagation in normal volunteers and in patients with central serous chorioretinopathy. Brit J Ophthalmol. 2010;94(3):289–91.CrossRef
13.
go back to reference Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Brit J Ophthalmol. 2003;87(6):709–12.CrossRef Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Brit J Ophthalmol. 2003;87(6):709–12.CrossRef
14.
go back to reference Gardiner P, Schrode K, Quinlan D, et al. Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol. 1989;29(4):342–7.PubMedCrossRef Gardiner P, Schrode K, Quinlan D, et al. Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol. 1989;29(4):342–7.PubMedCrossRef
15.
go back to reference Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina-J Ret Vit Dis. 2012;32(9):1829–37. Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina-J Ret Vit Dis. 2012;32(9):1829–37.
16.
17.
go back to reference Sakurada Y, Leong B, Parikh R, Fragiotta S, Freund KB. Association between choroidal caverns and choroidal vascular hyperpermeability in eyes with pachychoroid diseases. Retina-J Ret Vit Dis. 2018;38(10):1977–83. Sakurada Y, Leong B, Parikh R, Fragiotta S, Freund KB. Association between choroidal caverns and choroidal vascular hyperpermeability in eyes with pachychoroid diseases. Retina-J Ret Vit Dis. 2018;38(10):1977–83.
18.
go back to reference Ciloglu E, Unal F, Dogan NC. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Graef Arch Clin Exp. 2018;256(6):1111–6.CrossRef Ciloglu E, Unal F, Dogan NC. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Graef Arch Clin Exp. 2018;256(6):1111–6.CrossRef
19.
go back to reference Gackle HC, Lang GE, Freissler KA, Lang GK. Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects. Ophthalmologe. 1998;95(8):529–33.PubMedCrossRef Gackle HC, Lang GE, Freissler KA, Lang GK. Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects. Ophthalmologe. 1998;95(8):529–33.PubMedCrossRef
20.
go back to reference Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology. 2008;115(1):169–73.PubMedCrossRef Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology. 2008;115(1):169–73.PubMedCrossRef
21.
go back to reference Tanaka C, Iwahashi C, Komuku Y, Hozumi K, Mitarai K, Gomi F. Clinical characteristics of central serous chorioretinopathy in patients by age. JPN J Ophthalmol. 2021;65(6):761–8.PubMedCrossRef Tanaka C, Iwahashi C, Komuku Y, Hozumi K, Mitarai K, Gomi F. Clinical characteristics of central serous chorioretinopathy in patients by age. JPN J Ophthalmol. 2021;65(6):761–8.PubMedCrossRef
22.
go back to reference Singh SR, Iovino C, Zur D, et al. Central serous chorioretinopathy imaging biomarkers. Brit J Ophthalmol. 2022;106(4):553–8.CrossRef Singh SR, Iovino C, Zur D, et al. Central serous chorioretinopathy imaging biomarkers. Brit J Ophthalmol. 2022;106(4):553–8.CrossRef
23.
go back to reference Brinks J, van Dijk E, Meijer OC, Schlingemann RO, Boon C. Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities. ACTA Ophthalmol. 2022;100(8):946–59.PubMedPubMedCentralCrossRef Brinks J, van Dijk E, Meijer OC, Schlingemann RO, Boon C. Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities. ACTA Ophthalmol. 2022;100(8):946–59.PubMedPubMedCentralCrossRef
24.
go back to reference Theocharis IP, Lima LH. Vitreoretinal interface in central serous choroidopathy: a retrospective case-control study. ACTA Ophthalmol. 2012;90(7):e505–11.PubMedCrossRef Theocharis IP, Lima LH. Vitreoretinal interface in central serous choroidopathy: a retrospective case-control study. ACTA Ophthalmol. 2012;90(7):e505–11.PubMedCrossRef
25.
go back to reference Nair U, Ganekal S, Soman M, Nair K. Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity. CLIN Ophthalmol. 2012;6:1949–54.PubMedPubMedCentral Nair U, Ganekal S, Soman M, Nair K. Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity. CLIN Ophthalmol. 2012;6:1949–54.PubMedPubMedCentral
26.
go back to reference Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. AM J Ophthalmol. 2009;148(1):105–10.PubMedCrossRef Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. AM J Ophthalmol. 2009;148(1):105–10.PubMedCrossRef
27.
go back to reference Deng K, Gui Y, Cai Y, et al. Changes in the foveal outer nuclear layer of central serous chorioretinopathy patients over the disease course and their response to photodynamic therapy. Front Med-Lausanne. 2021;8: 824239.PubMedCrossRef Deng K, Gui Y, Cai Y, et al. Changes in the foveal outer nuclear layer of central serous chorioretinopathy patients over the disease course and their response to photodynamic therapy. Front Med-Lausanne. 2021;8: 824239.PubMedCrossRef
28.
go back to reference Asano KS, Asaoka R, Asano S, Azuma K, Inoue T, Obata R. Elongated photoreceptor outer segment length and prognosis of chronic central serous chorioretinopathy. Retina-J Ret Vit Dis. 2020;40(4):750–7. Asano KS, Asaoka R, Asano S, Azuma K, Inoue T, Obata R. Elongated photoreceptor outer segment length and prognosis of chronic central serous chorioretinopathy. Retina-J Ret Vit Dis. 2020;40(4):750–7.
29.
go back to reference Hasegawa T, Okamoto M, Masuda N, Ueda T, Ogata N. Relationship between foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy. Graef Arch Clin Exp. 2015;253(3):343–50.CrossRef Hasegawa T, Okamoto M, Masuda N, Ueda T, Ogata N. Relationship between foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy. Graef Arch Clin Exp. 2015;253(3):343–50.CrossRef
30.
go back to reference Yang L, Jonas JB, Wei W. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2013;54(7):4659–65.PubMedCrossRef Yang L, Jonas JB, Wei W. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2013;54(7):4659–65.PubMedCrossRef
31.
go back to reference Shin YU, Lee BR. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy. Am J Ophthalmol. 2012;154(1):155–63.PubMedCrossRef Shin YU, Lee BR. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy. Am J Ophthalmol. 2012;154(1):155–63.PubMedCrossRef
32.
go back to reference Liang Z, Qu J, Huang L, et al. Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin. Eye. 2021;35(2):418–24.PubMedCrossRef Liang Z, Qu J, Huang L, et al. Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin. Eye. 2021;35(2):418–24.PubMedCrossRef
33.
go back to reference Zhang X, Sivaprasad S. Drusen and pachydrusen: the definition, pathogenesis, and clinical significance. Eye. 2021;35(1):121–33.PubMedCrossRef Zhang X, Sivaprasad S. Drusen and pachydrusen: the definition, pathogenesis, and clinical significance. Eye. 2021;35(1):121–33.PubMedCrossRef
34.
go back to reference Kim JH, Chang YS, Kim JW, Lee TG, Kim CG. Prevalence of subtypes of reticular pseudodrusen in newly diagnosed exudative age-related macular degeneration and polypoidal choroidal vasculopathy in Korean patients. Retina-J Ret Vit Dis. 2015;35(12):2604–12. Kim JH, Chang YS, Kim JW, Lee TG, Kim CG. Prevalence of subtypes of reticular pseudodrusen in newly diagnosed exudative age-related macular degeneration and polypoidal choroidal vasculopathy in Korean patients. Retina-J Ret Vit Dis. 2015;35(12):2604–12.
35.
go back to reference Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina-J Ret Vit Dis. 2018;38(4):708–16. Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina-J Ret Vit Dis. 2018;38(4):708–16.
36.
go back to reference Matsumoto H, Mukai R, Morimoto M, Tokui S, Kishi S, Akiyama H. Clinical characteristics of pachydrusen in central serous chorioretinopathy. Graef Arch Clin Exp. 2019;257(6):1127–32.CrossRef Matsumoto H, Mukai R, Morimoto M, Tokui S, Kishi S, Akiyama H. Clinical characteristics of pachydrusen in central serous chorioretinopathy. Graef Arch Clin Exp. 2019;257(6):1127–32.CrossRef
37.
go back to reference Kim YH, Chung YR, Kim C, Lee K, Lee WK. The association of pachydrusen characteristics with choroidal thickness and patient’s age in polypoidal choroidal vasculopathy versus central serous chorioretinopathy. Int J Mol Sci. 2022;23(15):8353.PubMedPubMedCentralCrossRef Kim YH, Chung YR, Kim C, Lee K, Lee WK. The association of pachydrusen characteristics with choroidal thickness and patient’s age in polypoidal choroidal vasculopathy versus central serous chorioretinopathy. Int J Mol Sci. 2022;23(15):8353.PubMedPubMedCentralCrossRef
38.
go back to reference Sheth J, Anantharaman G, Kumar N, et al. Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum. Eye. 2020;34(9):1501–3.PubMedPubMedCentralCrossRef Sheth J, Anantharaman G, Kumar N, et al. Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum. Eye. 2020;34(9):1501–3.PubMedPubMedCentralCrossRef
39.
go back to reference Teo K, Cheong KX, Ong R, et al. Macular neovascularization in eyes with pachydrusen. Sci Rep-UK. 2021;11(1):7495.CrossRef Teo K, Cheong KX, Ong R, et al. Macular neovascularization in eyes with pachydrusen. Sci Rep-UK. 2021;11(1):7495.CrossRef
40.
go back to reference Lee SE, Lim HB, Shin YI, Ryu CK, Lee WH, Kim JY. Characteristics of the inner retinal layer in the fellow eyes of patients with unilateral exudative age-related macular degeneration. PLoS One. 2020;15(9): e239555. Lee SE, Lim HB, Shin YI, Ryu CK, Lee WH, Kim JY. Characteristics of the inner retinal layer in the fellow eyes of patients with unilateral exudative age-related macular degeneration. PLoS One. 2020;15(9): e239555.
41.
go back to reference Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal Image Study. Retina-J Ret Vit Dis. 2019;39(4):670–8. Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal Image Study. Retina-J Ret Vit Dis. 2019;39(4):670–8.
42.
go back to reference Friedman E, Smith TR. Clinical and pathological study of choroidal lipid globules. Arch Ophthalmol. 1966;75(3):334–6.PubMedCrossRef Friedman E, Smith TR. Clinical and pathological study of choroidal lipid globules. Arch Ophthalmol. 1966;75(3):334–6.PubMedCrossRef
43.
go back to reference Dolz-Marco R, Glover JP, Gal-Or O, et al. Choroidal and sub-retinal pigment epithelium caverns: multimodal imaging and correspondence with Friedman lipid globules. Ophthalmology. 2018;125(8):1287–301.PubMedCrossRef Dolz-Marco R, Glover JP, Gal-Or O, et al. Choroidal and sub-retinal pigment epithelium caverns: multimodal imaging and correspondence with Friedman lipid globules. Ophthalmology. 2018;125(8):1287–301.PubMedCrossRef
45.
go back to reference Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res. 2021;81: 100884.PubMedCrossRef Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res. 2021;81: 100884.PubMedCrossRef
46.
go back to reference Borrelli E, Battista M, Sacconi R, et al. OCT risk factors for 3-year development of macular complications in eyes with “resolved” chronic central serous chorioretinopathy. Am J Ophthalmol. 2021;223:129–39.PubMedCrossRef Borrelli E, Battista M, Sacconi R, et al. OCT risk factors for 3-year development of macular complications in eyes with “resolved” chronic central serous chorioretinopathy. Am J Ophthalmol. 2021;223:129–39.PubMedCrossRef
Metadata
Title
Chronic Central Serous Chorioretinopathy in Elderly Subjects: Structure and Blood Flow Characteristics of Retina and Choroid
Authors
Pei Liu
Haixin Fang
Guangqi An
Bo Jin
Chenyu Lu
Shu Li
Fan Yang
Liping Du
Xuemin Jin
Publication date
15-11-2023
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 1/2024
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-023-00849-z

Other articles of this Issue 1/2024

Ophthalmology and Therapy 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine